Publications by authors named "H Marzo-Ortega"
Article Synopsis
- * Research into the axial form of PsA (axPsA) is limited due to difficulties in identifying clinical indicators and a lack of specific biomarkers.
- * A group of rheumatology experts has compiled recommendations based on existing literature and their clinical experience to help diagnose and manage axial PsA in clinical settings.
Objective: To assess the effect of bimekizumab on pain, morning stiffness, and fatigue in patients with nonradiographic and radiographic axial spondyloarthritis (axSpA) in the phase III BE MOBILE studies (ClinicalTrials.gov: NCT03928704 and NCT03928743).
Methods: Patients were randomized to bimekizumab 160 mg or placebo every 4 weeks; and all patients received bimekizumab from week 16.